Daniel Clair to Peripheral Arterial Disease
This is a "connection" page, showing publications Daniel Clair has written about Peripheral Arterial Disease.
Connection Strength
3.292
-
A review of percutaneous deep vein arterialization for the treatment of nonreconstructable chronic limb threatening ischemia. Semin Vasc Surg. 2021 Dec; 34(4):188-194.
Score: 0.707
-
PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results. J Vasc Surg. 2021 11; 74(5):1626-1635.
Score: 0.686
-
Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease. JACC Cardiovasc Interv. 2019 12 23; 12(24):2515-2524.
Score: 0.612
-
The EPIC nitinol stent system in the treatment of iliac artery lesions: one-year results from the ORION clinical trial. J Endovasc Ther. 2014 Apr; 21(2):213-22.
Score: 0.418
-
Current state of diagnosis and management of critical limb ischemia. Curr Cardiol Rep. 2012 Apr; 14(2):160-70.
Score: 0.364
-
Interim Results of the PROMISE I Trial to Investigate the LimFlow System of Percutaneous Deep Vein Arterialization for the Treatment of Critical Limb Ischemia. J Invasive Cardiol. 2019 03; 31(3):57-63.
Score: 0.147
-
Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence. Vasc Med. 2018 12; 23(6):558-559.
Score: 0.143
-
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015 Mar; 61(3 Suppl):2S-41S.
Score: 0.111
-
Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the DEFINITIVE Ca?? trial. Catheter Cardiovasc Interv. 2014 Aug 01; 84(2):236-44.
Score: 0.104